Nektar Therapeutics
Biotechnology
Healthcare
NKTR
14.06 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
59.10
52 week high
59.60
high
61.06
52 week low
0.00
low
58.12
growth
593.83 %
previous Close
58.89
P/E ratio
market cap
390 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
486.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top